Dunn, Rosanne (University of Technology, Sydney. Faculty of Science, 1995)
In recent years a number of therapeutically useful immunotoxins have been produced using recombinant gene technology. In general, this involves fusion of a toxin gene with sequence encoding a variety of clinically relevant ...